Biome secures distribution with Fullscript Canada
| Stock | Biome Australia Ltd (BIO.ASX) |
|---|---|
| Release Time | 2 Feb 2026, 8:20 a.m. |
| Price Sensitive | Yes |
Biome secures distribution with Fullscript Canada
- Biome's Activated Probiotics products approved for launch on Fullscript Canada platform
- Fullscript serves over 100,000 healthcare practitioners and 5 million patients across North America
- Partnership complements existing Ecotrend Ecologics relationship to deliver complete Canadian market coverage
Microbiome health company Biome Australia Limited (ASX: BIO) has secured distribution for its entire Canadian range on Fullscript, North America's dominant practitioner distribution platform, and agreed on commercial terms. The Fullscript partnership represents a significant milestone in Biome's Canadian expansion, providing access to the dominant platform for practitioner-to-patient supplement dispensing across the region. The North American integrative medicine market has grown at a 25% CAGR, with approximately 80% of healthcare professionals now recommending supplements in some capacity. Canada's practitioner channel is anchored by Naturopathic Doctors (NDs), a rigorous four-year postgraduate medical qualification that positions these practitioners as trusted authorities in integrative health. The Fullscript partnership is strategically complementary to Biome's existing partnership with Ecotrend Ecologics, one of Canada's leading natural health products distributors with over 30 years of industry expertise. Together, these partnerships deliver comprehensive coverage of the Canadian practitioner market across both traditional wholesale distribution (Ecotrend) and direct-to-patient digital dispensing (Fullscript).
This partnership demonstrates continued momentum in Biome's Vision 27 international expansion strategy. The company is systematically building scale across key markets, including Canada, Ireland, New Zealand and the UK, establishing Biome as a truly global leader in evidence-based microbiome health. Fullscript's broader platform reach positions Biome well for ongoing growth opportunities.